SPAC APAC shareholders approve merger with Ligand spinoff OmniAb (NASDAQ:AHPA) 2022/10/25 17:44:15 Seeking Alpha SPAC Avista Public Acquisition Corp. II (AHPA) shareholders have approved a proposed merger with Ligand Pharmaceuticals'' (LGND) transgenic animal-generated antibody business OmniAb.